Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Insights, Forecast to 2029
This report presents an overview of global market for Gastrointestinal Stromal Tumor Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Gastrointestinal Stromal Tumor Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Stromal Tumor Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Stromal Tumor Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera and GeneChem, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gastrointestinal Stromal Tumor Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Gastrointestinal Stromal Tumor Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Stromal Tumor Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Stromal Tumor Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Yin Feng Gene, KingMed, Geneis, Haplox, AmoyDX, Admera and GeneChem, etc.
By Company
- Yin Feng Gene
- KingMed
- Geneis
- Haplox
- AmoyDX
- Admera
- GeneChem
- PCR
- FISH
- DNA Sequencing
- Gene Chip
- Clinical Diagnosis
- Drug Screening
- Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gastrointestinal Stromal Tumor Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2018-2029)
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Region
2.2.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Gastrointestinal Stromal Tumor Molecular Diagnostics by Players
3.1.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2022
3.5 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GASTROINTESTINAL STROMAL TUMOR MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 GASTROINTESTINAL STROMAL TUMOR MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
8.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
8.2.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
8.2.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
8.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
8.3.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
8.3.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
9.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
9.2.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
9.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
9.3.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
9.4 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region
9.4.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.1.5 Yin Feng Gene Recent Developments
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.2.5 KingMed Recent Developments
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.3.5 Geneis Recent Developments
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.4.5 Haplox Recent Developments
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.5.5 AmoyDX Recent Developments
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.6.5 Admera Recent Developments
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.7.5 GeneChem Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2018-2029)
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Region
2.2.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Gastrointestinal Stromal Tumor Molecular Diagnostics by Players
3.1.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2022
3.5 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GASTROINTESTINAL STROMAL TUMOR MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 GASTROINTESTINAL STROMAL TUMOR MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
8.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
8.2.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
8.2.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
8.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
8.3.1 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
8.3.3 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
9.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
9.2.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
9.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
9.3.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
9.4 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region
9.4.1 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.1.5 Yin Feng Gene Recent Developments
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.2.5 KingMed Recent Developments
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.3.5 Geneis Recent Developments
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.4.5 Haplox Recent Developments
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.5.5 AmoyDX Recent Developments
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.6.5 Admera Recent Developments
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
11.7.5 GeneChem Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2024-2029)
Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2022)
Table 19. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Application (2024-2029)
Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Yin Feng Gene Company Details
Table 66. Yin Feng Gene Business Overview
Table 67. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 68. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Yin Feng Gene Recent Developments
Table 70. KingMed Company Details
Table 71. KingMed Business Overview
Table 72. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 73. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 74. KingMed Recent Developments
Table 75. Geneis Company Details
Table 76. Geneis Business Overview
Table 77. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 78. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Geneis Recent Developments
Table 80. Haplox Company Details
Table 81. Haplox Business Overview
Table 82. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 83. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Haplox Recent Developments
Table 85. AmoyDX Company Details
Table 86. AmoyDX Business Overview
Table 87. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 88. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 89. AmoyDX Recent Developments
Table 90. Admera Company Details
Table 91. Admera Business Overview
Table 92. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 93. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Admera Recent Developments
Table 95. GeneChem Company Details
Table 96. GeneChem Business Overview
Table 97. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 98. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 99. GeneChem Recent Developments
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2024-2029)
Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2022)
Table 19. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Application (2024-2029)
Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Yin Feng Gene Company Details
Table 66. Yin Feng Gene Business Overview
Table 67. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 68. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Yin Feng Gene Recent Developments
Table 70. KingMed Company Details
Table 71. KingMed Business Overview
Table 72. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 73. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 74. KingMed Recent Developments
Table 75. Geneis Company Details
Table 76. Geneis Business Overview
Table 77. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 78. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Geneis Recent Developments
Table 80. Haplox Company Details
Table 81. Haplox Business Overview
Table 82. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 83. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Haplox Recent Developments
Table 85. AmoyDX Company Details
Table 86. AmoyDX Business Overview
Table 87. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 88. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 89. AmoyDX Recent Developments
Table 90. Admera Company Details
Table 91. Admera Business Overview
Table 92. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 93. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Admera Recent Developments
Table 95. GeneChem Company Details
Table 96. GeneChem Business Overview
Table 97. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 98. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 99. GeneChem Recent Developments
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered
Figure 13. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2022
Figure 19. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 22. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 23. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 27. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 28. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 29. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 37. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 38. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 40. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 41. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2018-2029)
Figure 42. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 52. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 59. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 60. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 61. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 62. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 63. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 64. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered
Figure 13. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2022
Figure 19. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 22. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 23. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 27. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 28. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 29. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 37. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 38. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 40. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 41. Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2018-2029)
Figure 42. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2018-2029)
Figure 52. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 59. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 60. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 61. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 62. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 63. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 64. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
